ABOUT THE EVENT
Date: Monday, September 22, 2025 8am–6:15pm PDT
Event Location: San Francisco , California
hubXchange invites you to the Antibody Therapeutics Xchange – San Francisco 2025, an exclusive, highly interactive event that unites senior-level scientists and executives from leading pharmaceutical and biotech organizations. This one-day forum will address cutting-edge innovations and real-world challenges across the full spectrum of antibody drug development.
What to Expect
7 Scientific Tracks:
- Target Selection & Mechanisms of Action
- Lead Identification & Optimization
- Formats & Scaffolds
- Bi/Multispecifics
- AI & Machine Learning
- ADC Linker Design & Conjugation Technologies
- ADC Cytotoxic Payload
Session Formats:
- Roundtable Discussions
- Keynote & Spotlight Presentations
- Poster Presentations
- Pre-booked 1-2-1 Partnering Meetings
- Networking Breaks & Drinks Reception
Agenda Highlights
Keynote Speakers Include:
- Pavel Ryzhov, Sr. Business Development Manager – WuXi Biologics
- Jordon Wang, Chief Operating Officer – AvantGen
- Alon Wellner, VP Biology & Co-Founder – Aureka Bio
Roundtable Highlights:
- Danielle Dettling (Fury Biosciences): Using existing targets for effective therapeutics
- Anthony Maida (Oncotelic Therapeutics): Managing immune-related toxicities in bispecifics
- Sayantan Mitra (BigHat Biosciences): AI/ML-assisted antibody engineering – hype or revolution?
- Sachin Shivatare (Eli Lilly): Optimizing ADC linkers for specificity and payload efficacy
Poster Highlights:
- Bio-Rad: Rapid Lead Generation with the Pioneer Antibody Discovery Platform
- Evitria: Solving the bispecific antibody mispairing challenge
- GenScript: TurboCHO for next-gen BsAb manufacturing
Why Attend?
- Participate in deep-dive discussions with scientific peers
- Discover emerging trends and technologies in antibody drug development
- Build meaningful 1:1 partnerships through curated networking
- Gain exclusive insights from industry pioneers
